These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37349645)

  • 1. GSK3β-driven SOX2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma.
    Kang L; Liu Y; He J; Wang Y; Xue M; Wu X; Wang Z; Zhang Y; Chu M; Li J; Wei W; Li J; Li E; Liao L; Xiao J; Zhang R; Xu L; Wong J
    Oncogene; 2023 Jul; 42(30):2297-2314. PubMed ID: 37349645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
    Bolidong D; Domoto T; Uehara M; Sabit H; Okumura T; Endo Y; Nakada M; Ninomiya I; Miyashita T; Wong RW; Minamoto T
    Sci Rep; 2020 Jul; 10(1):11807. PubMed ID: 32678196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity.
    Gao S; Li S; Duan X; Gu Z; Ma Z; Yuan X; Feng X; Wang H
    Mol Carcinog; 2017 Oct; 56(10):2301-2316. PubMed ID: 28574599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.
    Gen Y; Yasui K; Nishikawa T; Yoshikawa T
    Cancer Sci; 2013 Jul; 104(7):810-6. PubMed ID: 23510069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
    Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
    Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox2 induces tumorigenesis and angiogenesis of early-stage esophageal squamous cell carcinoma through secretion of Suprabasin.
    Takahashi K; Asano N; Imatani A; Kondo Y; Saito M; Takeuchi A; Jin X; Saito M; Hatta W; Asanuma K; Uno K; Koike T; Masamune A
    Carcinogenesis; 2020 Nov; 41(11):1543-1552. PubMed ID: 32055838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK1.
    Xu T; Yan Z; Lu J; Chen L; Li X; Li Y; Dong Z; Guo W
    Clin Exp Metastasis; 2022 Oct; 39(5):757-769. PubMed ID: 35715622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal regulation of LINC00941 and SOX2 promotes progression of esophageal squamous cell carcinoma.
    Lu JT; Yan ZY; Xu TX; Zhao F; Liu L; Li F; Guo W
    Cell Death Dis; 2023 Jan; 14(1):72. PubMed ID: 36717549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence.
    Wu Z; Zhou J; Zhang X; Zhang Z; Xie Y; Liu JB; Ho ZV; Panda A; Qiu X; Cejas P; Cañadas I; Akarca FG; McFarland JM; Nagaraja AK; Goss LB; Kesten N; Si L; Lim K; Liu Y; Zhang Y; Baek JY; Liu Y; Patil DT; Katz JP; Hai J; Bao C; Stachler M; Qi J; Ishizuka JJ; Nakagawa H; Rustgi AK; Wong KK; Meyerson M; Barbie DA; Brown M; Long H; Bass AJ
    Nat Genet; 2021 Jun; 53(6):881-894. PubMed ID: 33972779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
    Deng F; Zhou K; Cui W; Liu D; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting SOX2 Protein with Peptide Aptamers for Therapeutic Gains against Esophageal Squamous Cell Carcinoma.
    Liu K; Xie F; Zhao T; Zhang R; Gao A; Chen Y; Li H; Zhang S; Xiao Z; Li J; Hong X; Shang L; Huang W; Wang J; El-Rifai W; Zaika A; Chen X; Que J; Lan X
    Mol Ther; 2020 Mar; 28(3):901-913. PubMed ID: 31991109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.
    Gen Y; Yasui K; Zen Y; Zen K; Dohi O; Endo M; Tsuji K; Wakabayashi N; Itoh Y; Naito Y; Taniwaki M; Nakanuma Y; Okanoue T; Yoshikawa T
    Cancer Genet Cytogenet; 2010 Oct; 202(2):82-93. PubMed ID: 20875870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA MIAT promotes esophageal squamous cell carcinoma progression by regulating miR-1301-3p/INCENP axis and interacting with SOX2.
    Zhang C; Xie L; Fu Y; Yang J; Cui Y
    J Cell Physiol; 2020 Nov; 235(11):7933-7944. PubMed ID: 31943174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D; He X; Wang W; Hu X; Wang K; Wang M
    Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Nakade H; Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Miyao S; Sho M
    Int J Clin Oncol; 2020 Mar; 25(3):446-455. PubMed ID: 31535245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the SOX2/PARP1 complex to intervene in the growth of esophageal squamous cell carcinoma.
    Wang Z; Wang J; Zhao H; Zhao T; Chen Y; Jiang M; Zhang S; Wei Y; Zhang J; Zhou Y; Shi S; Fu Z; Yang Y; Zhang Y; Yang L; Que J; Liu K
    Biomed Pharmacother; 2022 Sep; 153():113309. PubMed ID: 35738180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3β.
    Liu RM; Sun DN; Jiao YL; Wang P; Zhang J; Wang M; Ma J; Sun M; Gu BL; Chen P; Liu K; Ma H; Gao SG; Ma YF; Qi YJ
    Cancer Lett; 2018 Jan; 412():289-296. PubMed ID: 29079416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of the SOX2 protein in the development of esophagus and esophageal squamous cell carcinoma, and pharmacological target for therapy.
    Zhang J; Wang Z; Zhao H; Wei Y; Zhou Y; Zhang S; Zhao J; Li X; Lin Y; Liu K
    Biomed Pharmacother; 2023 Jul; 163():114764. PubMed ID: 37100016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorogenic acid inhibits esophageal squamous cell carcinoma growth in vitro and in vivo by downregulating the expression of BMI1 and SOX2.
    Zhan Y; Li R; Feng C; Li X; Huang S; Wang L; Liu Z; Jiang J; Han Y
    Biomed Pharmacother; 2020 Jan; 121():109602. PubMed ID: 31707349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.
    Jiang Y; Zhang J; Zhao J; Li Z; Chen H; Qiao Y; Chen X; Liu K; Dong Z
    BMC Cancer; 2019 Dec; 19(1):1264. PubMed ID: 31888532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.